Baystreet Staff -

Medical Instruments and Supplies Industry's Stocks Get Research Review

[ACCESSWIRE]

LONDON, UK / ACCESSWIRE / June 2, 2016 / ActiveWallSt.com announces the list of stocks for today's research coverage. Pre-market the Active Wall St. team provides the latest corporate, market and technical events impacting selected stocks on the Medical Instruments and Supplies industry. Companies recently under review include Baxter Intl., Skyline Medical, TransEnterix, and DENTSPLY Intl. Register with us now for your free membership and see our complete reports on these equities at:

http://www.activewallst.com/register/

Today, ActiveWallSt.com is promoting its equity research coverage. Get all of our research report free by signing up to http://www.activewallst.com/register/.

The U.S. Medical Instruments and Supplies market remains to be the largest in the world, and it is expected to grow even more by the end of this year. With increasing competition in the industry, investors are scanning the markets for growth opportunities. Let us see how the current market environment is affecting some of the big names in the industry. Get the full story on these stocks by visiting:

http://www.activewallst.com/register/

ActiveWallSt.com takes a brief technical look at how each of the companies mentioned above have fared over the last few trading sessions and more.

Baxter International Inc. (NYSE: BAX)

Illinois-based renal and hospital products provider, Baxter International Inc.'s stock finished Wednesday's session 0.39% higher at $43.33 with a total volume of 4.76 million shares traded. The Company's shares have advanced 9.12% over the previous three months and 13.91% on an YTD basis. The stock is trading above its 50-day and 200-day moving averages by 0.39% and 12.71%, respectively. Furthermore, shares of Baxter International have a Relative Strength Index (RSI) of 45.27.

Skyline Medical Inc. (NASDAQ: SKLN)

On Wednesday, shares in Minnesota-based medical device Company, Skyline Medical Inc., ended the session at $0.14, which was a correction of 4.86%. The stock recorded a trading volume of 2.18 million shares. The Company's shares are trading 28.10% below their 50-day moving average. Moreover, Skyline Medical's stock has an RSI of 38.94.

TransEnterix Inc. (AMEX: TRXC)

TransEnterix Inc. is a medical device Company that focuses on the development and commercialization of surgical robotic systems. The Company's stock ended yesterday's session 2.73% higher at $1.88 with a total volume of 770,803 shares traded. The Company's shares have advanced 22.08% in the past month. The stock is trading 33.84% below its 200-day moving average. Additionally, shares of TransEnterix have an RSI of 38.89. On May 11th, 2016, research firm Lake Street downgraded the Company's stock rating from 'Buy' to 'Hold'.

DENTSPLY International Inc. (NASDAQ: XRAY)

At the close on Wednesday, shares in York, Pennsylvania-based dental consumable products provider, DENTSPLY International Inc., recorded a trading volume of 1.39 million shares. The stock finished 0.51% higher at $62.48. The Company's shares have advanced 3.70% in the last one month, 3.92% in the previous three months, and 2.81% on an YTD basis. The stock is trading above its 50-day and 200-day moving averages by 2.69% and 6.94%, respectively. Furthermore, shares of DENTSPLY International have an RSI of 57.41. On May 13th, 2016, research firm Barrington Research reiterated its 'Outperform' rating with an increase of the target price to $68 a share from $62 a share for the Company's stock.

Active Wall Street:

Active Wall Street (AWS) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. AWS has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

AWS has not been compensated; directly or indirectly; for producing or publishing this document.

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a third party research service company (the "Reviewer") represented by a credentialed financial analyst [for further information on analyst credentials, please email [email protected]. Rohit Tuli, a CFA® charterholder (the "Sponsor"), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by AWS. AWS is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.   

NO WARRANTY

AWS, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. AWS, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, AWS, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither AWS nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://www.activewallst.com/disclaimer/.

CONTACT

For any questions, inquiries, or comments reach out to us directly at:
Office Address: 3rd floor, 207 Regent Street, London, W1B 3HH, United Kingdom
Email: [email protected]
Phone number: 1-858-257-3144

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: Active Wall Street